List of Tables
Table 1. Late Stage Chronic Kidney Disease Drugs Market Trends
Table 2. Late Stage Chronic Kidney Disease Drugs Market Drivers & Opportunity
Table 3. Late Stage Chronic Kidney Disease Drugs Market Challenges
Table 4. Late Stage Chronic Kidney Disease Drugs Market Restraints
Table 5. Global Late Stage Chronic Kidney Disease Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Late Stage Chronic Kidney Disease Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Late Stage Chronic Kidney Disease Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of Late Stage Chronic Kidney Disease Drugs
Table 10. Global Late Stage Chronic Kidney Disease Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Late Stage Chronic Kidney Disease Drugs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Late Stage Chronic Kidney Disease Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Late Stage Chronic Kidney Disease Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Late Stage Chronic Kidney Disease Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Late Stage Chronic Kidney Disease Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Late Stage Chronic Kidney Disease Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Late Stage Chronic Kidney Disease Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Late Stage Chronic Kidney Disease Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Late Stage Chronic Kidney Disease Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Late Stage Chronic Kidney Disease Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Late Stage Chronic Kidney Disease Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Late Stage Chronic Kidney Disease Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Late Stage Chronic Kidney Disease Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Late Stage Chronic Kidney Disease Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Late Stage Chronic Kidney Disease Drugs Sales Value by Region (2019-2024) & (%)
Table 27. Global Late Stage Chronic Kidney Disease Drugs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Late Stage Chronic Kidney Disease Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Late Stage Chronic Kidney Disease Drugs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Late Stage Chronic Kidney Disease Drugs Sales Value, (2025-2030) & (US$ Million)
Table 31. AbbVie Basic Information List
Table 32. AbbVie Description and Business Overview
Table 33. AbbVie Late Stage Chronic Kidney Disease Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Late Stage Chronic Kidney Disease Drugs Business of AbbVie (2019-2024)
Table 35. AbbVie Recent Developments
Table 36. Amgen Basic Information List
Table 37. Amgen Description and Business Overview
Table 38. Amgen Late Stage Chronic Kidney Disease Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Late Stage Chronic Kidney Disease Drugs Business of Amgen (2019-2024)
Table 40. Amgen Recent Developments
Table 41. Ardelyx Basic Information List
Table 42. Ardelyx Description and Business Overview
Table 43. Ardelyx Late Stage Chronic Kidney Disease Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Late Stage Chronic Kidney Disease Drugs Business of Ardelyx (2019-2024)
Table 45. Ardelyx Recent Developments
Table 46. AstraZeneca Basic Information List
Table 47. AstraZeneca Description and Business Overview
Table 48. AstraZeneca Late Stage Chronic Kidney Disease Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Late Stage Chronic Kidney Disease Drugs Business of AstraZeneca (2019-2024)
Table 50. AstraZeneca Recent Developments
Table 51. Deltanoid Basic Information List
Table 52. Deltanoid Description and Business Overview
Table 53. Deltanoid Late Stage Chronic Kidney Disease Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Late Stage Chronic Kidney Disease Drugs Business of Deltanoid (2019-2024)
Table 55. Deltanoid Recent Developments
Table 56. Akebia Therapeutics Basic Information List
Table 57. Akebia Therapeutics Description and Business Overview
Table 58. Akebia Therapeutics Late Stage Chronic Kidney Disease Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Late Stage Chronic Kidney Disease Drugs Business of Akebia Therapeutics (2019-2024)
Table 60. Akebia Therapeutics Recent Developments
Table 61. Kyowa Hakko Kirin Basic Information List
Table 62. Kyowa Hakko Kirin Description and Business Overview
Table 63. Kyowa Hakko Kirin Late Stage Chronic Kidney Disease Drugs Products, Services and Solutions
Table 64. Revenue (US$ Million) in Late Stage Chronic Kidney Disease Drugs Business of Kyowa Hakko Kirin (2019-2024)
Table 65. Kyowa Hakko Kirin Recent Developments
Table 66. OPKO Health Basic Information List
Table 67. OPKO Health Description and Business Overview
Table 68. OPKO Health Late Stage Chronic Kidney Disease Drugs Products, Services and Solutions
Table 69. Revenue (US$ Million) in Late Stage Chronic Kidney Disease Drugs Business of OPKO Health (2019-2024)
Table 70. OPKO Health Recent Developments
Table 71. Vifor Pharma Basic Information List
Table 72. Vifor Pharma Description and Business Overview
Table 73. Vifor Pharma Late Stage Chronic Kidney Disease Drugs Products, Services and Solutions
Table 74. Revenue (US$ Million) in Late Stage Chronic Kidney Disease Drugs Business of Vifor Pharma (2019-2024)
Table 75. Vifor Pharma Recent Developments
Table 76. Sanofi Basic Information List
Table 77. Sanofi Description and Business Overview
Table 78. Sanofi Late Stage Chronic Kidney Disease Drugs Products, Services and Solutions
Table 79. Revenue (US$ Million) in Late Stage Chronic Kidney Disease Drugs Business of Sanofi (2019-2024)
Table 80. Sanofi Recent Developments
Table 81. Shield Therapeutics Basic Information List
Table 82. Shield Therapeutics Description and Business Overview
Table 83. Shield Therapeutics Late Stage Chronic Kidney Disease Drugs Products, Services and Solutions
Table 84. Revenue (US$ Million) in Late Stage Chronic Kidney Disease Drugs Business of Shield Therapeutics (2019-2024)
Table 85. Shield Therapeutics Recent Developments
Table 86. Shire Basic Information List
Table 87. Shire Description and Business Overview
Table 88. Shire Late Stage Chronic Kidney Disease Drugs Products, Services and Solutions
Table 89. Revenue (US$ Million) in Late Stage Chronic Kidney Disease Drugs Business of Shire (2019-2024)
Table 90. Shire Recent Developments
Table 91. Spectrum Basic Information List
Table 92. Spectrum Description and Business Overview
Table 93. Spectrum Late Stage Chronic Kidney Disease Drugs Products, Services and Solutions
Table 94. Revenue (US$ Million) in Late Stage Chronic Kidney Disease Drugs Business of Spectrum (2019-2024)
Table 95. Spectrum Recent Developments
Table 96. ZS Pharma Basic Information List
Table 97. ZS Pharma Description and Business Overview
Table 98. ZS Pharma Late Stage Chronic Kidney Disease Drugs Products, Services and Solutions
Table 99. Revenue (US$ Million) in Late Stage Chronic Kidney Disease Drugs Business of ZS Pharma (2019-2024)
Table 100. ZS Pharma Recent Developments
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. Late Stage Chronic Kidney Disease Drugs Downstream Customers
Table 104. Late Stage Chronic Kidney Disease Drugs Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Late Stage Chronic Kidney Disease Drugs Product Picture
Figure 2. Global Late Stage Chronic Kidney Disease Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Late Stage Chronic Kidney Disease Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Late Stage Chronic Kidney Disease Drugs Report Years Considered
Figure 5. Global Late Stage Chronic Kidney Disease Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Late Stage Chronic Kidney Disease Drugs Revenue in 2023
Figure 7. Late Stage Chronic Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Calcimimetics Picture
Figure 9. Vitamin D Sterols Picture
Figure 10. Potassium Binders Picture
Figure 11. Others Picture
Figure 12. Global Late Stage Chronic Kidney Disease Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Late Stage Chronic Kidney Disease Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Hospital Pharmacies
Figure 15. Product Picture of Online Pharnacies
Figure 16. Product Picture of Retail Pharmacies
Figure 17. Global Late Stage Chronic Kidney Disease Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Late Stage Chronic Kidney Disease Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Late Stage Chronic Kidney Disease Drugs Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Late Stage Chronic Kidney Disease Drugs Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Late Stage Chronic Kidney Disease Drugs Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Late Stage Chronic Kidney Disease Drugs Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Late Stage Chronic Kidney Disease Drugs Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Late Stage Chronic Kidney Disease Drugs Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Late Stage Chronic Kidney Disease Drugs Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Late Stage Chronic Kidney Disease Drugs Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Late Stage Chronic Kidney Disease Drugs Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Late Stage Chronic Kidney Disease Drugs Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Late Stage Chronic Kidney Disease Drugs Sales Value (%), (2019-2030)
Figure 30. United States Late Stage Chronic Kidney Disease Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Late Stage Chronic Kidney Disease Drugs Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Late Stage Chronic Kidney Disease Drugs Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Late Stage Chronic Kidney Disease Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Late Stage Chronic Kidney Disease Drugs Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Late Stage Chronic Kidney Disease Drugs Sales Value by Application (%), 2023 VS 2030
Figure 36. China Late Stage Chronic Kidney Disease Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Late Stage Chronic Kidney Disease Drugs Sales Value by Type (%), 2023 VS 2030
Figure 38. China Late Stage Chronic Kidney Disease Drugs Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Late Stage Chronic Kidney Disease Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Late Stage Chronic Kidney Disease Drugs Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Late Stage Chronic Kidney Disease Drugs Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Late Stage Chronic Kidney Disease Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Late Stage Chronic Kidney Disease Drugs Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Late Stage Chronic Kidney Disease Drugs Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Late Stage Chronic Kidney Disease Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Late Stage Chronic Kidney Disease Drugs Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Late Stage Chronic Kidney Disease Drugs Sales Value by Application (%), 2023 VS 2030
Figure 48. India Late Stage Chronic Kidney Disease Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Late Stage Chronic Kidney Disease Drugs Sales Value by Type (%), 2023 VS 2030
Figure 50. India Late Stage Chronic Kidney Disease Drugs Sales Value by Application (%), 2023 VS 2030
Figure 51. Late Stage Chronic Kidney Disease Drugs Industrial Chain
Figure 52. Late Stage Chronic Kidney Disease Drugs Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
